|
|
| | Voruciclib Basic information |
| Product Name: | Voruciclib | | Synonyms: | Voruciclib;2-[2-Chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-4H-1-benzopyran-4-one;UNII-W66XP666AM;2-(2-chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one;CS-2788;P1446A 05;P1446A05;P1446A-05 | | CAS: | 1000023-04-0 | | MF: | C22H19ClF3NO5 | | MW: | 469.84 | | EINECS: | | | Product Categories: | | | Mol File: | 1000023-04-0.mol |  |
| | Voruciclib Chemical Properties |
| Boiling point | 587.6±50.0 °C(Predicted) | | density | 1.493±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: soluble | | form | A crystalline solid | | pka | 6.36±0.40(Predicted) | | color | Light yellow to yellow |
| | Voruciclib Usage And Synthesis |
| Uses | Voruciclib is a cyclin-dependent kinase (CDK) inhibitor. It is a derivative of Flavone (F371050) and can be used for treatment of proliferative disorders such as cancer. |
| | Voruciclib Preparation Products And Raw materials |
|